Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(13%)
Results Posted
40%(2 trials)

Phase Distribution

Ph not_applicable
2
25%
Ph phase_1
3
38%
Ph phase_3
1
13%
Ph phase_4
2
25%

Phase Distribution

3

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
3(37.5%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Other(2)

Detailed Status

Completed5
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (37.5%)
Phase 31 (12.5%)
Phase 42 (25.0%)
N/A2 (25.0%)

Trials by Status

completed563%
recruiting113%
unknown225%

Recent Activity

1 active trials
Showing 5 of 8
recruitingphase_4

Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.

NCT06291363
completedphase_1

Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers

NCT01113515
completednot_applicable

Effect of Dexmedetomidine vs Esmolol or Placebo on Cerebral Hemodynamics in Septic Shock

NCT06169475
completedphase_3

Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers

NCT03998436
unknownnot_applicable

The Impact of Esmolol Administration on Postoperative Recovery

NCT05567822
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06291363Phase 4

Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.

Recruiting
NCT01113515Phase 1

Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers

Completed
NCT06169475Not Applicable

Effect of Dexmedetomidine vs Esmolol or Placebo on Cerebral Hemodynamics in Septic Shock

Completed
NCT03998436Phase 3

Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers

Completed
NCT05567822Not Applicable

The Impact of Esmolol Administration on Postoperative Recovery

Unknown
NCT02967029Phase 4

Effect of Controlled Hypotension on Cerebral Oxygen Saturation

Completed
NCT03892512Phase 1

Dexmedetomidine and Esmolol Early Post Operative Cognitive Dysfunction

Unknown
NCT01652898Phase 1

A Pharmacokinetic, Pharmacodynamic, Safety Study With AOP LDLA202, ONO LDL50 and Esmolol in Healthy Volunteers

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8